Bill Mitchell

Bill Mitchell is an Executive in Residence with Frazier Healthcare Partners on the Growth Buyout team. He represents Frazier on the boards of CSafe Global and Adare Pharma Solutions. Bill first joined Frazier Healthcare Partners in 2012 as part of the PCI diligence team and after successfully closing the acquisition, he led PCI until mid-2019. Mr. Mitchell returned to Frazier as a repeat Executive in Residence after serving seven years as President and CEO of PCI Pharma Services, a Frazier portfolio company. Between stints at PCI, he also served as CEO of Clondalkin Group’s North American pharma packaging operations.